Mark Foley

Chief Executive Officer, Revance Therapeutics, Inc.
Brentwood, Tennessee,United States
Find Mark Foley's Email
Find Mark Foley's Phone

Who Is Mark Foley?

Total Experience59 years
CompanyRevance Therapeutics, Inc.
CountryUnited States

Mark Foley is a highly accomplished executive and board member with over three decades of leadership experience in the medical technology and life sciences industries. He is widely recognized for his role as President and CEO of Zeltiq Aesthetics, where he spearheaded the global expansion of the CoolSculpting brand, leading to the company's $2.47 billion acquisition by Allergan. Prior to Zeltiq, Foley held senior leadership positions at Guidant Corporation, where he was instrumental in driving the growth of its vascular intervention business. Today, he leverages his expertise in commercial strategy, market development, and corporate governance by serving on the boards of several innovative healthcare companies, guiding the next generation of medical technology.

Mark Foley LinkedIn pageCompany Website

How Did Mark Foley's Career Path Shape Their Journey?

Mark Foley's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Revance Therapeutics, Inc. - Chief Executive Officer(2019 to Present)
ULab - Chairman(2015 to Present)
Glaukos Corporation - Board Member(2014 to Present)
Aesthetic Innovation Summit - Co-Chair of the Aesthetic Innovation Summit (AIS)(2017 to 2020)
RWI Ventures - Managing Director(2004 to 2018)
ZELTIQ - Chairman, President & CEO(2012 to 2017)
Onpharma - Executive Chairman(2009 to 2014)

What Are Mark Foley's Key Achievements?

Zeltiq Aesthetics Acquisition

As President and CEO, successfully led Zeltiq Aesthetics, the company behind CoolSculpting, through a phase of explosive growth, culminating in a landmark $2.47 billion acquisition by Allergan in 2017.

Guidant Corporation Market Leadership

Held multiple executive roles at Guidant, significantly contributing to the expansion of its endovascular division and establishing its market-leading position in stent and cardiac rhythm management technologies.

Strategic Board and Advisory Roles

Actively serves as Chairman of the Board or a board member for several disruptive companies, including Revance Therapeutics and R-Zero, providing strategic oversight for commercialization and corporate growth.

What's Mark Foley's Educational Background?

Bachelor's Degree

University of Notre Dame - Year 1983

Buying Intent Signals for Mark Foley

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Revance Therapeutics, Inc.
Total employees766
HeadquartersNashville
Founded2002

Revance Therapeutics is a biotechnology company focused on delivering innovative aesthetic and therapeutic products. The company is known for its proprietary Peptide Fusion Platform and its flagship product, DAXXIFY® (DaxibotulinumtoxinA-lanm), a long-lasting neuromodulator for treating facial wrinkles. Revance aims to transform the patient experience and set new standards in the aesthetics market by providing cutting-edge, science-based solutions.

Company Website
Revance Therapeutics, Inc. Stock Information
Revance Therapeutics, Inc., Inc. is listed on the NASDAQ under the ticker symbol RVNC. The company went public on February 6, 2014

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Intent Signals

Buyer intent signals

CRM Enrichment

Contact Enrichment

Workflows and tasks

Workflows and tasks

Integrations

Integrations

Thousands of companies, including, are just a search away.